Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed to manage type 2 diabetes and, more recently, approved for chronic weight management
MacroFactor: Food logging, body metric tracking, and more, starting at $5.99 per month
Note: Patients with heart failure or kidney disease should follow their provider's fluid intake recommendations
and Canada and may be approved for people with obesity by the end of this year
In addition, some peoples bodies cannot properly use the carnitine they get from their diets
The mechanism is not fully understood, but it may relate to reduced caloric intake, altered glucose metabolism, or direct central nervous system effects